Supervision Guidelines for Psychedelic Practitioners (AMAPP)

AMAPP Date of Creation: 20/04/2023
Last Edited: 7/6/2023

To obtain full accreditation as a Psychedelic Therapist or Psychedelic Facilitator, supervised practice must be undertaken in the form of video recorded sessions submitted for viewing by the supervisor or working as a co-therapist with an accredited supervisor in dosing sessions. Due to the limited number of potential supervisors available in the initial stages of the commencement of psychedelic- assisted psychotherapy, Psychedelic Therapists and Psychedelic Facilitators will be able to work with provisional accreditation whilst undertaking their supervised practice. Therapists and Facilitators must complete a minimum of two dosing sessions in order to obtain full accreditation.

AMAPP- Accredited Supervisors

The following outlines the requirements to receive AMAPP-Accredited Supervisor status:

  • Training and qualifications in delivering therapy (e.g. Psychologists, Psychiatrists, Psychotherapists) and eligibility for accreditation as a Psychedelic Therapist

  • A minimum of 2 years’ experience in a supervisory or mentoring role to peers or students

  • A minimum of four dosing sessions experience over a minimum 12-month period

  • Experience providing psychedelic-assisted psychotherapy through all stages of preparation, dosing and integration

  • Availability of Supervisors

    AMAPP acknowledges that Psychedelic-Assisted Psychotherapy is in its infancy in Australia, with several trials now underway and an increasing number of training programs available to prospective psychedelic-assisted psychotherapists globally. Therefore, AMAPP acknowledges that there will be a limited number of Psychedelic Therapists who would meet all requirements for accreditation status in Australia under the prospective guidelines. AMAPP proposes a two-phased introduction of the above standards to receive AMAPP-Accredited Supervisor Status. The initial accreditation phase is proposed to be effective from 1 July 2023 until 1 July 2025, with review by the AMAPP credentialing committee after this period. The second phase is implementation of the full AMAPP-accredited supervisor requirements.

Initial phase: 1st July 2023- 1st July 2025:

During the initial phase: AMAPP-Accredited Supervisor Status is open to persons in the field who demonstrate all three of the following requirements:

They have completed a minimum of four dosing sessions, and have experience providing psychedelic-assisted psychotherapy through all stages of preparation, dosing and integration
 • They have experience in clinical trial settings working with psychedelics such as MDMA or psilocybin, or experience working with ketamine or cannabis in community-based settings

They provide a reference letter from colleagues or supervisors who have worked with them in a co-therapist or supervisor capacity and can attest to their knowledge and skill in delivering safe and effective psychedelic-assisted psychotherapy. This includes appropriate overseas-trained supervisors who are providing supervision to Australian- based Therapists and Facilitators

Second phase: 1st July 2025 onwards

At the end of the initial accreditation phase (1 July 2025 onwards), the AMAPP Credentialling subcommittee will review the suitability to implement the full accreditation standards for AMAPP Accredited Supervisor Status. The committee will be considering workforce skills and practicalities balanced with the need to ensure quality training standards.

Obtaining Full Accreditation

At the end of the period of the Therapist/Facilitator’s supervised practice (i.e., once two dosing sessions and six hours of supervision have been completed), the Therapist/Facilitator will provide a letter from their supervisor confirming that they have completed the required supervision hours to obtain full accreditation status.


Last modified: Friday, 9 February 2024, 6:07 PM